CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 54 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $336,000 | -71.5% | 83,607 | -74.0% | 0.03% | -76.7% |
Q4 2018 | $1,180,000 | -57.2% | 321,430 | 0.0% | 0.13% | -58.0% |
Q3 2018 | $2,758,000 | -25.2% | 321,430 | -4.3% | 0.32% | -37.7% |
Q2 2018 | $3,689,000 | -0.5% | 335,987 | +4.5% | 0.51% | -9.6% |
Q1 2018 | $3,706,000 | +61.6% | 321,430 | +45.2% | 0.56% | +109.3% |
Q4 2017 | $2,294,000 | -35.0% | 221,430 | 0.0% | 0.27% | -46.6% |
Q3 2017 | $3,530,000 | +13.2% | 221,430 | -14.1% | 0.50% | -4.9% |
Q2 2017 | $3,118,000 | -46.2% | 257,665 | -7.7% | 0.53% | -53.2% |
Q1 2017 | $5,798,000 | +26.6% | 279,166 | -12.8% | 1.13% | -2.2% |
Q4 2016 | $4,579,000 | -14.4% | 320,229 | -1.5% | 1.16% | +33.1% |
Q3 2016 | $5,347,000 | +16.8% | 325,053 | 0.0% | 0.87% | -26.7% |
Q2 2016 | $4,577,000 | +184.6% | 325,053 | +193.0% | 1.19% | +240.4% |
Q1 2016 | $1,608,000 | – | 110,921 | – | 0.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ADAMS STREET PARTNERS LLC | 3,275,616 | $7,501,161 | 1.96% |
TOWERVIEW LLC | 205,000 | $469,450 | 0.31% |
Orbimed Advisors | 6,943,654 | $15,900,968 | 0.29% |
CHI Advisors LLC | 200,000 | $458,000 | 0.14% |
BVF INC/IL | 1,370,947 | $3,139,469 | 0.09% |
SAMLYN CAPITAL, LLC | 2,105,930 | $4,822,580 | 0.08% |
MYDA Advisors LLC | 100,000 | $229,000 | 0.07% |
DIFESA CAPITAL MANAGEMENT, LP | 10,000 | $22,900 | 0.06% |
JACKSON SQUARE CAPITAL, LLC | 63,773 | $146,040 | 0.06% |
CORNERCAP INVESTMENT COUNSEL INC | 97,248 | $222,698 | 0.04% |